Suppr超能文献

原发性胃B细胞淋巴瘤:一项前瞻性多中心研究的结果。德奥胃肠道淋巴瘤研究组

Primary gastric B-cell lymphoma: results of a prospective multicenter study. The German-Austrian Gastrointestinal Lymphoma Study Group.

作者信息

Fischbach W, Dragosics B, Kolve-Goebeler M E, Ohmann C, Greiner A, Yang Q, Böhm S, Verreet P, Horstmann O, Busch M, Dühmke E, Müller-Hermelink H K, Wilms K, Allinger S, Bauer P, Bauer S, Bender A, Brandstätter G, Chott A, Dittrich C, Erhart K, Eysselt D, Ellersdorfer H, Ferlitsch A, Fridrik M A, Gartner A, Hausmaninger M, Hinterberger W, Hügel K, Ilsinger P, Jonaus K, Judmaier G, Karner J, Kerstan E, Knoflach P, Lenz K, Kandutsch A, Lobmeyer M, Michlmeier H, Mach H, Marosi C, Ohlinger W, Oprean H, Pointer H, Pont J, Salabon H, Samec H J, Ulsperger A, Wimmer A, Wewalka F

机构信息

Medizinische Klinik II, Klinikum Aschaffenburg, Aschaffenburg, Germany.

出版信息

Gastroenterology. 2000 Nov;119(5):1191-202. doi: 10.1053/gast.2000.19579.

Abstract

BACKGROUND & AIMS: Appropriate management of primary gastric lymphoma is controversial. This prospective, multicenter study aimed to evaluate the accuracy of endoscopic biopsy diagnosis and clinical staging procedures and assess a treatment strategy based on Helicobacter pylori status and tumor stage and grade.

METHODS

Of 266 patients with primary gastric B-cell lymphoma, 236 with stages EI (n = 151) or EII (n = 85) were included in an intention-to-treat analysis. Patients with H. pylori-positive stage EI low-grade lymphoma underwent eradication therapy. Nonresponders and patients with stage EII low-grade lymphoma underwent gastric surgery. Depending on the residual tumor status and predefined risk factors, patients received either radiotherapy or no further treatment. Patients with high-grade lymphoma underwent surgery and chemotherapy at stages EI/EII, complemented by radiation in case of incomplete resection.

RESULTS

Endoscopic-bioptic typing and grading and clinical staging were accurate to 73% and 70%, respectively, based on the histopathology of resected specimens. The overall 2-year survival rates for low-grade lymphoma did not differ in the risk-adjusted treatment groups, ranging from 89% to 96%. In high-grade lymphoma, patients with complete resection or microscopic tumor residuals had significantly better survival rates (88% for EI and 83% for EII) than those with macroscopic tumor residues (53%; P < 0.001).

CONCLUSIONS

There is a considerable need for improvement in clinical diagnostic and staging procedures, especially with a view toward nonsurgical treatment. With the exception of eradication therapy in H. pylori-positive low-grade lymphoma of stage EI and the subgroup of locally advanced high-grade lymphoma, resection remains the treatment of choice. However, because there is an increasing trend toward stomach-conserving therapy, a randomized trial comparing cure of disease and quality of life with surgical and conservative treatment is needed.

摘要

背景与目的

原发性胃淋巴瘤的恰当管理存在争议。这项前瞻性多中心研究旨在评估内镜活检诊断和临床分期程序的准确性,并基于幽门螺杆菌状态、肿瘤分期和分级评估一种治疗策略。

方法

在266例原发性胃B细胞淋巴瘤患者中,236例处于EI期(n = 151)或EII期(n = 85)的患者纳入意向性分析。幽门螺杆菌阳性的EI期低级别淋巴瘤患者接受根除治疗。无反应者和EII期低级别淋巴瘤患者接受胃部手术。根据残留肿瘤状态和预先确定的风险因素,患者接受放疗或不再接受进一步治疗。高级别淋巴瘤患者在EI/EII期接受手术和化疗,若切除不完全则辅以放疗。

结果

基于切除标本的组织病理学,内镜活检分型、分级及临床分期的准确率分别为73%和70%。在风险调整治疗组中,低级别淋巴瘤的总体2年生存率无差异,范围为89%至96%。在高级别淋巴瘤中,完全切除或显微镜下有肿瘤残留的患者生存率(EI期为88%,EII期为83%)显著高于有肉眼可见肿瘤残留的患者(53%;P < 0.001)。

结论

临床诊断和分期程序有很大的改进需求,尤其是考虑到非手术治疗。除了对EI期幽门螺杆菌阳性低级别淋巴瘤及局部晚期高级别淋巴瘤亚组进行根除治疗外,手术仍然是首选治疗方法。然而,由于保胃治疗的趋势日益增加,需要进行一项随机试验,比较手术和保守治疗在疾病治愈和生活质量方面的差异。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验